Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Abortion foes urge justices to allow limits on abortion drug

Lawyers for anti-abortion doctors are urging the Supreme Court to allow restrictions to take effect on a drug used in the most common method of abortion in the United States, while a lawsuit continues

The Independent UK

Why Top 1% Biotech Madrigal Pharmaceuticals Just Surged Closer To A Breakout

Madrigal snagged a breakthrough therapy designation for its liver disease treatment on Tuesday and MDGL stock surged closer to a buy point.

Investors Business Daily

Tesco to close eight in-store pharmacies this year as part of huge shake-up

Tesco announced in January that was to introduce a raft of changes to the business in order to “remain focused and competitive in a fast-changing market”

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

Bellus Health Soars 99% As GSK Joins Buyout Bonanza With $2 Billion Deal

GSK added to a series of recent takeovers Tuesday with the $2 billion acquisition of Bellus Health. But BLU stock and GSK stock diverged.

Investors Business Daily

Johnson & Johnson Tops Q1 Earnings Forecast On Consumer Unit Gains, Boosts Dividend

“Our first quarter results demonstrate strong performance across all three segments of our business," said CEO Joaquin Duato.

The Street

Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom

Merck is acquiring Prometheus Bio in a well-timed $10.8 billion deal ahead of Keytruda's patent loss. The news sent RXDX stock flying Monday.

Investors Business Daily

Conservatives love judicial activism – as long as the law is moved in their favor

Brazen judicial overreach to curb abortion access proves the right wing will abandon their principles to get their way

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Supreme Court blocks lower court rulings restricting abortion pills

The court's decision comes less than a year after it overturned Roe v. Wade, arguing it did not have the power to create abortion policy.

Axios

Biden administration asks US supreme court to halt abortion pill restrictions

Limits slated to go into effect at 12.01am Saturday following lower court’s order revoking the FDA’s approval of mifepristone

The Guardian - US

DOJ, drugmaker ask SCOTUS to intervene in abortion drug case

WASHINGTON — The Justice Department and a pharmaceutical company on Friday asked the Supreme Court to intervene in the court fight over a commonly used abortion drug in order to keep a court ruling restricting availability of the drug from taking effect this weekend.

Tribune News Service

Abortion pill could be unavailable for months without Supreme Court action-U.S. DOJ

New court-imposed restrictions on the abortion pill mifepristone could cut off access to the drug entirely for months, the Biden administration and the drug's distributor, Danco Laboratories, said in petitions asking the U.S. Supreme Court to lift the curbs.

Reuters

The Unexpected Way The Texas Abortion Ruling Could Destroy Biotech

A judge's decision in Texas to outlaw an abortion drug undermines the foundation of all biotech stocks, a group of nearly 600 executives says.

Investors Business Daily

Commentary: Abortion pill ruling means more painful, later terminations

The conservative 5th Circuit has blocked part of a Texas judge’s decision to pull abortion drug mifepristone off the market, but leaves in place onerous and outdated restrictions that the Food and Drug Administration determined in 2016 were medically unnecessary.

Tribune News Service

Abortion pill mifepristone: timeline of US access

Washington (AFP) - Mifepristone, a drug widely used in the United States to induce abortion in women pregnant for 10 weeks or less, has become a target of the country's anti-abortion movement.

AFP

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Sarepta Tumbles As Report Of Internal FDA Strife Scorches Its Gene Therapy

Several FDA staffers were leaning toward rejecting a highly watched gene therapy from Sareptas, according to a report Thursday.

Los Angeles Times

Abortion’s new battleground: Mifepristone’s effect on women’s mental health

At the heart of the latest battle over abortion access is a federal judge’s ruling that cites concern about the mental health of women who choose to end their pregnancies.

Investors Business Daily

Trillions In Biotech Stock Gains Trace Back To This Financier

Frank did not grow up as son of a Wall Street banker. He began as the consummate outsider.

The Independent UK

Court preserves access to abortion drug, tightens rules

A federal appeals court has preserved access to an abortion drug for now but under tighter rules that would allow the drug only to be dispensed up to seven weeks, not 10, and not by mail

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Pharmaceutical executives challenge Texas court’s abortion pill ruling

Gilead Sciences and Pfizer join amicus brief

The Guardian - US

US drug tsar warns xylazine tranquilizer mixed with fentanyl is ‘emerging threat’

Dr Rahul Gupta says drug has become increasingly common nationwide and is particularly dangerous when mixed with opioid fentanyl

The Independent UK

US names veterinary drug, fentanyl mixture 'emerging threat'

The U.S. Office of National Drug Control Policy is designating the tranquilizer xylazine when mixed with fentanyl as an emerging threat

Tribune News Service

Lisa Jarvis: Abortion pill ruling threatens pharmaceutical innovation

A Texas federal judge’s ruling to remove the 23-year-old drug mifepristone from the market not only threatens abortion access in the U.S. — it’s also an appalling sideswipe at the Food and Drug Administration’s authority and expertise.

Tribune News Service

Abortion drug rulings spur drugmaker worries about precedent

WASHINGTON — Experts worry two recent rulings challenging the Food and Drug Administration’s regulation of a drug used in medication abortions threaten to complicate the agency’s oversight and the pipeline for future research and drug approvals.

Salon

GOP sadism proudly on display

The abortion pill decision proves, yet again, that there's nothing "pro-life" about Republicans

Tribune News Service

Legal fight over abortion drug could quickly hit Supreme Court

WASHINGTON — The Justice Department and several Democrat-led states took steps Monday to preserve access to a commonly used medication abortion drug after dueling federal court rulings about its availability.

1 … 41 42 43 44

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Food and Drug Administration

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.